BRO vs CTOR · P/E 30, rev $4.80B vs $105.2M cap
Brown & Brown Inc (BRO) versus Citius Oncology, Inc. (CTOR) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
CTOR does not have a complete income-statement cache yet.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. CTOR currently screens at market cap $105.2M.
Not investment advice. Open the BRO and CTOR stock pages for the full models.
Not investment advice.